http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9319786-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82a9e0557767c0f1cf096619d9309046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_462325f221dcfe3742675fadc2eaaaa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4de8db13891c64ecd7a04f46577f137
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-24
filingDate 1993-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae52866b365e7699466132700d8a6c30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4653c5edbd76fad3fa41e1a80131f260
publicationDate 1993-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9319786-A1
titleOfInvention High affinity, strongly neutralizing monoclonal antibodies against the cd-4 binding site of gp120 of human immunodeficiency virus
abstract mAbs are described which have high affinity for, and strongly neutralize, HIV-1. The mAbs are specific for an epitope that is partially or completely within the CD-4 binding site of gp120.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9890207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9493549-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013090644-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013090644-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013192589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5474894-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9879068-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11149081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013016468-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472868-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2230250-B1
priorityDate 1992-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128571533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1738118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226530546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129763036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409117

Total number of triples: 51.